Andrological characterization of the patient with diabetes mellitus

Minerva Endocrinologica

Volumn 34, Issue 1, 2009, Pages 1-9

  La Vignera, S ^a   Calogero, A E ^a   Condorelli, R ^a   Lanzafame, F ^b   Giammusso, B ^a   Vicari, E ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b ASL 3   (Italy)

Author keywords

Diabetes mellitus; Fertility; Hypogonadism; Urologic diseases

Indexed keywords

PHOSPHODIESTERASE V; TESTOSTERONE;

ADULT; ARTICLE; COLOR ULTRASOUND FLOWMETRY; DIABETES MELLITUS; DISEASE DURATION; ECOLOR DOPPLER PENILE DYNAMIC; ERECTILE DYSFUNCTION; HUMAN; HYPOGONADISM; LOWER URINARY TRACT SYMPTOM; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEMINAL VESICLE; SEXUAL DYSFUNCTION; SUBFERTILITY; TESTIS SIZE; URINARY TRACT INFECTION; ADOLESCENT; AGED; AZOOSPERMIA; BLOOD; MALE GENITAL SYSTEM; MALE INFERTILITY; MICROBIOLOGY; MIDDLE AGED; ORGAN SIZE; PATHOLOGY; PREVALENCE; RETROSPECTIVE STUDY; SPERM; SPERMATOZOON; ULTRASTRUCTURE;

ADOLESCENT; ADULT; AGED; AZOOSPERMIA; DIABETES COMPLICATIONS; ERECTILE DYSFUNCTION; GENITALIA, MALE; HUMANS; HYPOGONADISM; INFERTILITY, MALE; MALE; MIDDLE AGED; ORGAN SIZE; PREVALENCE; RETROSPECTIVE STUDIES; SEMEN; SPERMATOZOA; TESTOSTERONE; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 67650360231     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. May M, Gralla O, Knoll N, Fenske S, Spivak I, Rönnebeck C et al. Erectile dysfunction, discrepancy between high prevalence and low utilization of treatment options: results from the 'Cottbus Survey' with 10 000 men. BJU Int 2007;100:1110-5.
2. Eardley I, Fisher W, Rosen RC, Niederberger C, Nadel A, Sand M. The multinational Men's Attitudes to Life Events and Sexuality study: the influence of diabetes on self-reported erectile function, attitudes and treatment-seeking patterns in men with erectile dysfunction. Int J Clin Pract 2007;61:1446-53.
3. Meiland R, Geerlings SE, Hoepelman AI. Management of bacterial urinary tract infections in adult patients with diabetes mellitus. Drugs 2002;62:1859-68.
4. Kalyani RR, Dobs AS. Androgen deficiency, diabetes, and the metabolic syndrome in men. Curr Opin Endocrinol Diabetes Obes 2007;14:226-34.
5. Sarma AV, Burke JP, Jacobson DJ, McGree ME, St Sauver J, Girman CJ et al. Associations Between Diabetes and Clinical Markers of Benign Prostatic Hyperplasia among Community-Dwelling Black and White Men. Diabetes Care 2008;31:476-82.
6. Rodriguez-de-Velasquez A, Yoder IC, Velasquez PA, Papanicolaou N. Imaging the effects of diabetes on the genitourinary system. Radiographics 1995;15:1051-68.
7. Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin North Am 1997;11:735-50.
8. El-Sakka AI. Premature ejaculation in non-insulin-dependent diabetic patients. Int J Androl 2003;26:329-34.
9. Burke JP, Jacobson DJ, McGree ME, Nehra A, Roberts RO, Girman CJ et al. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men. J Urol 2007;177:1438-42.
10. Kendirci M, Trost L, Sikka SC, Hellstrom WJ.Diabetes mellitus is associated with severe Peyronie's disease. BJU Int 2007;99:383-6. (Pubitemid 46103121)
11. Agbaje IM, Rogers DA, McVicar CM, McClure N, Atkinson AB, Mallidis C et al. Insulin dependant diabetes mellitus: implications for male reproductive function. Hum Reprod 2007;22:1871-7.
12. La Vignera S, Calogero AE, Cannizzaro MA, Vicari E. Erectile vascular dysfunction and analysis of the risk factors related to it: clinical experience. Minerva Endocrinol 2007;32:17-21.
13. La Vignera S, Calogero AE, Cannizzaro MA, Condorelli R, Noto Z, Vicari E. Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment. Minerva Endocrinol 2006;31:251-61.
14. Vicari E, Di Pino L, La Vignera S, Fratantonio E, Signorelli S, Battiato C et al. Peak systolic velocity in patients with arterial erectile dysfunction and peripheral arterial disease. Int J Impot Res 2006;18:175-9. (Pubitemid 43336484)
15. Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Peña BM. Development and evaluation of an abridged, 5-item version of the international index of erectile function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999;11:319-26.
16. Aversa A, Sarteschi LM. The role of penile color-duplex ultrasound for the evaluation of erectile dysfunction. J Sex Med 2007;4:1437-47. (Pubitemid 47337692)
17. Behre HM, Kliesch S, Schädel F, Nieschlag E. Clinical relevance of scrotal and transrectal ultrasonography in andrological patients. Int J Androl 1995;(18 Suppl 2):27-31. (Pubitemid 26010504)
18. Fuse H, Takahara M, Ishii H, Sumiya H, Shimazaki J. Measurement of testicular volume by ultrasonography. Int J Androl 2000;23:248-53.
19. Villers A, Terris MK, McNeal JE, Stamey TA. Ultrasound anatomy of the prostate : the normal gland and anatomial variations. J Urol 1989;143:732-8.
20. La Vignera S, Calogero AE, Condorelli R, Garrone F, Vicari E. Spermiogram: techniques, interpretation, and prognostic value of results. Minerva Endocrinol 2007;32:115-26.
21. th edition. Geneva: World Health Organization; 1999.
22. El-Sakka AI. Association of risk factors and medical comorbidities with male sexual dysfunctions. J Sex Med 2007;4:1691-700.
23. La Vignera S, Calogero AE, Condorelli R, Giammusso B, Vicari E. Partial androgen deficiency of the aging male and clinical response to conventional medical therapy in patients with metabolic syndrome. Minerva Med 2007;98:101-7.
24. Kapoor D, Malkin CJ, Channer KS, Jones TH. Androgens, insulin resistance and vascular disease in men.Clin Endocrinol (Oxf) 2005;63:239-50.
25. Aversa A, Bruzziches R, Vitale C, Marazzi G, Francomano D, Barbara G et al. Chronic sildenafil in men with diabetes and erectile dysfunction. Expert Opin Drug Metab Toxicol 2007;3:451-64.
26. Kasturi S, Russell S, McVary KT. Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr Urol Rep 2006;7:288-92. (Pubitemid 44623888)
27. Berger AP, Bartsch G, Deibl M, Alber H, Pachinger O, Fritsche G et al. Atherosclerosis as a risk factor for benign prostatic hyperplasia. BJU Int 2006;98:1038-42. (Pubitemid 44536455)
28. Filippi S, Morelli A, Sandner P, Fibbi B, Mancina R, Marini M et al. Characterization and functional role of androgen-dependent PDE5 activity in the bladder. Endocrinology 2007;148:1019-29. (Pubitemid 46272788)
29. Vicari E, La Vignera S, Castiglione R, Calogero AE. Sperm parameter abnormalities, low seminal fructose and reactive oxygen species overproduction do not discriminate patients with unilateral or bilateral post-infectious inflammatory prostato-vesiculo-epididymitis. J Endocrinol Invest 2000;29:18-25.
30. La Vignera S, Calogero A.E., Condorelli R, Vicari E. Ultrasonographic aspects of altered ampullo-vescicular voiding as a sign of autonomic neuropathy. VII Congresso Nazionale della Società Italiana di Andrologia Medica. Firenze 9-11 Novembre 2006. Published on "Journal of Endocrinological Investigation". Pag 21; Vol.29, Suppl. to No.8,2006.
31. Mallidis C, Agbaje I, Rogers D, Glenn J, McCullough S, Atkinson AB et al. Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus. Hum Reprod 2007;22:2169-77. (Pubitemid 47241862)
32. Baccetti B, La Marca A, Piomboni P, Capitani S, Bruni E, Petraglia F et al. Insulin-dependent diabetes in men is associated with hypothalamo-pituitary derangement and with impairment in semen quality. Hum Reprod 2002;17:2673-7. (Pubitemid 35174121)
33. Perdichizzi A, Nicoletti F, La Vignera S, Barone N, D'Agata R, Vicari E et al. Effects of tumour necrosis factor-alpha on human sperm motility and apoptosis. J Clin Immunol. 2007;27:152-62. (Pubitemid 46348726)